OACC — Oaktree Acquisition III Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00- $261.81m
- $260.54m
Annual balance sheet for Oaktree Acquisition III Life Sciences, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K | 10-K | |
| Standards: | — | USG | USG |
| Status: | fx Preliminary | Final | Final |
| Cash | |||
| Cash and Short Term Investments | — | 1.36 | 1.43 |
| Prepaid Expenses | |||
| Total Current Assets | — | 1.56 | 1.55 |
| Other Long Term Assets | |||
| Total Assets | — | 195 | 203 |
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | — | 0.727 | 1.3 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | — | 7.75 | 8.32 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | — | 188 | 195 |
| Total Liabilities & Shareholders' Equity | — | 195 | 203 |
| Total Common Shares Outstanding |